Described herein are novel PRMT5 inhibitors of Formula I and pharmaceutically acceptable salts thereof, as well the pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity and may have use in treating proliferative, metabolic and blood disorders. Compounds of Formula I have the following structure:
本文介绍了一种新型的PR
MT5
抑制剂I型及其药物可接受的盐,以及其制备的药物组成物。本发明的化合物可用于抑制PR
MT5活性,并可用于治疗增殖性、代谢性和血液疾病。公式I的化合物具有以下结构: